Liver function may change how venglustat works in the body
NCT ID NCT05718258
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage study looked at how a single dose of venglustat is processed in people with mild, moderate, or severe liver problems compared to healthy adults. Twenty-six participants received one tablet and were monitored for about three weeks. The goal was to see if liver function affects drug levels and safety, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- venglustat
- What this could lead to
- If successful, this study could help doctors understand how to safely dose venglustat in patients with liver problems.
- What could go wrong
- This is an early, small study focused on drug processing, not treatment effects. Results may not apply to long-term use or other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC FUNCTION ABNORMAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
American Research Corporation Site Number : 8400005
San Antonio, Texas, 78215, United States
-
Clinical Pharmacology of Miami Site Number : 8400002
Miami, Florida, 33014, United States
-
Inland Empire Liver Foundation Site Number : 8400004
Rialto, California, 92377, United States
-
Investigational Site Number : 2760001
Kiel, 24105, Germany
-
Nucleus Network Site Number : 8400001
Saint Paul, Minnesota, 55114, United States
-
Volunteer Research Group-NOCCR Site Number : 8400003
Knoxville, Tennessee, 37920, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.